Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PMVP

PMV Pharmaceuticals Inc

Last Close
May 09 • 04:00PM ET
2.10
Dollar change
-0.06
Percentage change
-2.78 		%
Held by: VTI IWM VXF IWN SCHA VTWO IWC VHT AVSC VTWV Scroll to Statements
IndexRUT P/E- EPS (ttm)-1.44 Insider Own20.87% Shs Outstand51.45M Perf Week12.30%
Market Cap108.02M Forward P/E- EPS next Y-1.41 Insider Trans-0.81% Shs Float40.71M Perf Month39.07%
Income-68.96M PEG- EPS next Q-0.37 Inst Own88.43% Short Float6.83% Perf Quarter24.26%
Sales0.00M P/S- EPS this Y5.67% Inst Trans-5.23% Short Ratio4.59 Perf Half Y-3.67%
Book/sh4.39 P/B0.48 EPS next Y-3.95% ROA-26.40% Short Interest2.78M Perf Year-58.33%
Cash/sh3.96 P/C0.53 EPS next 5Y23.10% ROE-29.24% 52W Range1.17 - 9.72 Perf YTD-32.26%
Dividend Est.- P/FCF- EPS past 5Y-28.63% ROI-28.96% 52W High-78.40% Beta1.59
Dividend TTM- Quick Ratio14.78 Sales past 5Y0.00% Gross Margin- 52W Low78.72% ATR (14)0.12
Dividend Ex-Date- Current Ratio14.78 EPS Y/Y TTM10.20% Oper. Margin0.00% RSI (14)66.77 Volatility7.30% 6.55%
Employees63 Debt/Eq0.06 Sales Y/Y TTM- Profit Margin- Recom1.40 Target Price5.67
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q27.64% Payout- Rel Volume0.43 Prev Close2.16
Sales Surprise- EPS Surprise16.67% Sales Q/Q- EarningsMay 09 BMO Avg Volume606.48K Price2.10
SMA2017.12% SMA5020.42% SMA200-36.42% Trades Volume261,934 Change-2.78%
Date Action Analyst Rating Change Price Target Change
Apr-12-24Initiated Jefferies Buy $5
Dec-27-23Initiated Ladenburg Thalmann Buy $7
Mar-02-22Upgrade Oppenheimer Perform → Outperform $30
Sep-22-21Upgrade Goldman Neutral → Buy $35 → $43
Aug-19-21Initiated Oppenheimer Perform
Aug-02-21Initiated Guggenheim Buy $56
Jul-29-21Initiated H.C. Wainwright Buy $63
Oct-20-20Initiated Goldman Neutral $34
Oct-20-20Initiated Evercore ISI Outperform $60
Oct-20-20Initiated Cowen Outperform
Show Previous Ratings
Today 01:54PM
PMVP Stock Earnings: PMV Pharma Beats EPS for Q1 2024
(InvestorPlace)
08:00AM
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
(GlobeNewswire)
Mar-27-24 08:00AM
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
(GlobeNewswire)
Mar-18-24 04:01PM
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancer
(GlobeNewswire) -5.11%
Mar-01-24 10:21AM
PMV Pharmaceuticals Inc (PMVP) Reports Full Year 2023 Financial Results
(GuruFocus.com)
04:01PM Loading…
Feb-29-24 04:01PM
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
(GlobeNewswire)
Feb-26-24 08:00AM
PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
(GlobeNewswire) +7.78%
Jan-18-24 04:01PM
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
(GlobeNewswire) -5.76%
Jan-05-24 04:01PM
PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
(GlobeNewswire) -5.94%
Nov-09-23 09:41AM
PMV Pharmaceuticals Inc (PMVP) Reports Q3 2023 Financial Results and Corporate Updates
(GuruFocus.com)
08:00AM
PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
(GlobeNewswire)
Oct-16-23 09:35AM
PMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
(Zacks) -11.00%
Oct-12-23 12:30PM
PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation
(GlobeNewswire) -47.58%
Oct-11-23 12:00PM
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar
(GlobeNewswire) -26.01%
Oct-06-23 09:55AM
Wall Street Analysts See a 239.26% Upside in PMV Pharmaceuticals, Inc. (PMVP): Can the Stock Really Move This High?
(Zacks) +6.62%
04:05PM Loading…
Sep-20-23 04:05PM
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
(GlobeNewswire) +9.62%
Aug-30-23 09:55AM
Wall Street Analysts Think PMV Pharmaceuticals, Inc. (PMVP) Could Surge 182.64%: Read This Before Placing a Bet
(Zacks)
Aug-29-23 09:55AM
PMV Pharmaceuticals, Inc. (PMVP)'s Technical Outlook is Bright After Key Golden Cross
(Zacks)
Aug-09-23 08:00AM
PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights
(GlobeNewswire) +27.69%
Jun-06-23 04:01PM
PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference
(GlobeNewswire) +7.56%
May-10-23 08:00AM
PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights
(GlobeNewswire) +8.33%
Apr-14-23 11:51AM
We Think PMV Pharmaceuticals (NASDAQ:PMVP) Can Afford To Drive Business Growth
(Simply Wall St.)
Mar-01-23 08:00AM
PMV Pharmaceuticals Reports Full Year 2022 Financial Results and Corporate Highlights
(GlobeNewswire) -14.15%
Feb-28-23 04:05PM
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March
(GlobeNewswire)
Dec-08-22 09:55AM
Does PMV Pharmaceuticals, Inc. (PMVP) Have the Potential to Rally 267% as Wall Street Analysts Expect?
(Zacks)
Nov-22-22 08:00AM
PMV Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference
(GlobeNewswire) +5.02%
Nov-17-22 06:18PM
15 Most Shorted Stocks Right Now
(Insider Monkey)
Nov-08-22 08:00AM
PMV Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Highlights
(GlobeNewswire)
Nov-05-22 09:39AM
We Think PMV Pharmaceuticals (NASDAQ:PMVP) Can Afford To Drive Business Growth
(Simply Wall St.)
Nov-04-22 08:00AM
PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors
(GlobeNewswire)
12:00PM Loading…
Oct-11-22 12:00PM
PMV Pharmaceuticals, Inc. (PMVP) Upgraded to Buy: Here's What You Should Know
(Zacks)
Sep-23-22 09:19AM
10 Most Shorted Stocks in September
(Insider Monkey)
Aug-09-22 08:00AM
PMV Pharmaceuticals Reports Second Quarter 2022 Financial Results and Corporate Highlights
(GlobeNewswire) -8.06%
Jul-19-22 09:26AM
10 Most Shorted Stocks to Watch in July
(Insider Monkey) +5.81%
Jul-18-22 10:47AM
PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors
(Benzinga) -9.52%
08:00AM
PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors
(GlobeNewswire)
Jun-08-22 08:00AM
PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference
(GlobeNewswire) -5.71%
Jun-07-22 12:00PM
PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation
(GlobeNewswire) -21.70%
May-29-22 08:26AM
We're Not Very Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Rate
(Simply Wall St.)
May-26-22 05:05PM
PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
(GlobeNewswire)
May-20-22 03:04PM
Pennsylvania Biotech Center's economic impact grows to $7B as it expands in Bucks County, report finds
(American City Business Journals)
May-10-22 07:30AM
PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights
(GlobeNewswire) +9.66%
Apr-27-22 10:30AM
PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
(GlobeNewswire)
Mar-01-22 07:15AM
PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
(GlobeNewswire) +5.11%
Feb-28-22 08:00AM
PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference
(GlobeNewswire)
Feb-03-22 08:00AM
PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day
(GlobeNewswire)
Jan-12-22 12:20PM
Do Hedge Funds Love PMV Pharmaceuticals, Inc. (PMVP)?
(Insider Monkey)
Jan-06-22 08:00AM
PMV Pharma Announces Changes to its Board of Directors
(GlobeNewswire) -16.31%
Dec-20-21 10:28AM
We're Hopeful That PMV Pharmaceuticals (NASDAQ:PMVP) Will Use Its Cash Wisely
(Simply Wall St.)
Nov-22-21 08:00AM
PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference
(GlobeNewswire)
Nov-12-21 07:15AM
PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights
(GlobeNewswire)
Oct-05-21 11:33AM
Pmv Pharmaceuticals Insider Trades $440K In Company Stock
(Benzinga)
Sep-27-21 09:26PM
Goldman Sachs: Buy These 2 Stocks Before They Jump 40% (or More)
(TipRanks)
Sep-09-21 08:00AM
PMV Pharmaceuticals Appoints Tim Smith as Senior Vice President, Head of Corporate Development
(GlobeNewswire)
Sep-02-21 08:00AM
PMV Pharmaceuticals to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
(GlobeNewswire)
Aug-13-21 08:00AM
PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights
(GlobeNewswire)
Jul-19-21 06:19PM
Where Do Hedge Funds Stand On PMV Pharmaceuticals, Inc. (PMVP)?
(Insider Monkey)
Jun-23-21 05:38AM
We're Hopeful That PMV Pharmaceuticals (NASDAQ:PMVP) Will Use Its Cash Wisely
(Simply Wall St.)
Jun-09-21 08:00AM
PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference
(GlobeNewswire)
Jun-03-21 08:00AM
PMV Pharmaceuticals Announces Participation at the Goldman Sachs Annual Healthcare Conference
(GlobeNewswire)
May-14-21 08:00AM
PMV Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Highlights
(GlobeNewswire) +10.54%
May-05-21 08:00AM
PMV Pharmaceuticals Announces Participation at the Bank of America Healthcare Conference
(GlobeNewswire)
Apr-10-21 01:31PM
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
(GlobeNewswire)
Apr-06-21 08:00AM
PMV Pharma Strengthens Board of Directors with Appointment of Dr. Charles Baum
(GlobeNewswire)
Mar-10-21 04:31PM
PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021
(GlobeNewswire)
Mar-03-21 04:01PM
PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
(GlobeNewswire)
Feb-16-21 08:00AM
PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board
(GlobeNewswire) -9.57%
Dec-25-20 03:44AM
We're Not Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn
(Simply Wall St.)
Dec-16-20 03:19PM
Is PMVP A Good Stock To Buy Now?
(Insider Monkey)
Nov-24-20 05:00PM
PMV Pharmaceuticals to Present at Evercore ISI 3rd Annual HealthCONx Conference
(GlobeNewswire) +8.67%
Nov-23-20 08:00AM
PMV Pharma Doses First Patient in Phase 1/2 Study of PC14586, a First-in-Class Precision Oncology Therapy That Targets Mutant p53
(GlobeNewswire)
Nov-13-20 08:00AM
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
(GlobeNewswire) -5.50%
Oct-13-20 08:00AM
PMV Pharma Granted FDA Fast Track Designation of PC14586 for the Treatment of Advanced Cancer Patients that have Tumors with a p53 Y220C Mutation
(GlobeNewswire)
Oct-09-20 03:41PM
Janus Henderson and PMV Pharmaceuticals See Activist Action
(Barrons.com)
Oct-01-20 11:57AM
Biotech Pulmonx Shares Climb in Trading Debut
(Barrons.com)
Sep-29-20 04:05PM
PMV Pharma Announces Closing of $243.5 Million Initial Public Offering and Exercise in Full of Underwriters Option to Purchase Additional Shares
(GlobeNewswire) +5.00%
Sep-25-20 02:31PM
PMV Pharma Soars 115% as Biotech IPOs Take Off
(Barrons.com)
12:37PM
PMV Pharmaceutical's stock nearly doubles in its debut
(MarketWatch)
06:16AM
PMV Pharmaceuticals prices IPO at top end of expectations, raises $211.8 million
(MarketWatch)
Sep-24-20 08:06PM
PMV Pharma Announces Pricing of Initial Public Offering
(GlobeNewswire)
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORBIMED ADVISORS LLC10% OwnerNov 22 '23Sale2.2387,786195,7630Nov 24 04:38 PM
Mack David HenryPresident and CEOOct 18 '23Option Exercise0.53198,407105,156363,877Nov 13 04:21 PM
Alland LeilaChief Medical OfficerSep 15 '23Sale6.626,29141,64645,909Sep 18 04:22 PM
Jalota DeepikaChief Development OfficerSep 15 '23Sale6.624,10427,16829,946Sep 18 04:26 PM
Mack David HenryPresident and CEOAug 07 '23Option Exercise0.5385,50045,315165,470Aug 08 04:43 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.